Washington, D.C. Cannabis
Market Intelligence Report

Washington, D.C.'s cannabis market is unlike any state's. D.C. voters approved legalization of possession, home cultivation, and gifting for adults 21 and older through Initiative 71 in 2014 — but Congress has attached a budget rider, commonly called the "Harris Rider" after Rep. Andy Harris (R-MD), to every federal appropriations bill since, barring the District from spending any local or federal funds to tax or regulate commercial cannabis sales. D.C. remains the only U.S. jurisdiction where voters approved legalization yet the jurisdiction is legally prevented from building a regulated, taxed retail market.

The one legal storefront channel that does exist is the District's Medical Cannabis Program, regulated by the Alcoholic Beverage and Cannabis Administration (ABCA). A self-certification option lets any D.C. resident 21 or older register as a patient without a doctor's recommendation, which has pushed the program's reach well beyond a traditional medical population. That channel posted a record $6.5 million in sales in April 2026, even as a wave of new dispensary openings beginning in March 2025 has pressured average revenue per store. Outside this regulated channel, unlicensed "gifting" shops continue to operate under Initiative 71's gift allowance, forming an untaxed gray market the District cannot directly regulate.

D.C.'s population is younger and higher-income than the national median, a demographic profile consistent with sustained dispensary demand even within a federally-constrained market. (Official, Census ACS 2024)

ABCA regulates D.C.'s Medical Cannabis Program under seven license/permit types, with Retailer, Internet Retailer, Cultivation Center, Manufacturer, and Courier as the core commercial categories. As of the most recent reporting, no new application windows were open for any of these categories, meaning market entry is currently limited to existing or previously-awarded licensees. The program's self-certification option for adults 21 and older — requiring no doctor's recommendation — has broadened patient registration well beyond a conventional medical population.

D.C. periodically waives its medical cannabis sales tax through a Council-enacted "sales tax holiday," most recently around the 4/20 period in past years — though the future of this policy is uncertain given a pending proposal to raise the base rate from 6% to 10.25%.

D.C.'s cannabis supply chain runs entirely through a closed set of ABCA-licensed cultivation centers and manufacturers, since no new cultivation, manufacturing, or courier license windows are currently open. This constrained supply base serves both a growing patient population and an expanding count of retail storefronts, a combination that has driven product variety up even as no new growers can enter the licensed system in the near term.

D.C.'s medical program is showing a classic maturing-market pattern: total sales are climbing to record highs even as average revenue per store falls, reflecting a rapidly growing number of competing dispensaries chasing a patient base that, while large for a city of this size, is not growing as fast as store count.

Washington, D.C. has no counties; the closest geographic analog is its eight Wards. ABCA's dispensary locator shows licensed retailers spread across multiple Wards and commercial corridors citywide, but the District does not publish a ward-by-ward sales or license-count breakdown. (Not Available — ward-level sales detail.)

Cost benchmarks for D.C.'s capped, no-new-license medical market are harder to pin down than in open-license states, since ABCA does not publish itemized licensing costs separate from the broader business license fee schedule.

Vendor demand signal tracks which product and service categories D.C.-area medical cannabis operators are actively sourcing this quarter.

D.C. collects no dedicated cannabis excise tax revenue: the Harris Rider blocks the District from establishing the kind of commercial cannabis tax structure seen in adjacent Maryland or Virginia. The only cannabis-specific revenue mechanism is the District's general 6% sales tax as applied to medical purchases — a rate a June 2026 budget proposal seeks to raise to 10.25%. Based on the official April 2026 sales figure, a 6% rate on that single month's $6.5M would imply roughly $390,000 in that month's sales tax collections; the District does not publish a running cannabis-specific tax revenue total. (Modeled-Estimated, derived from official monthly sales figure.)

D.C. is bordered entirely by Maryland and Virginia, both of which have legalized adult-use possession — though Virginia, like D.C., has not yet stood up a regulated commercial retail market, creating an unusual regional pattern where two of three adjoining jurisdictions allow possession without a fully operational legal retail channel.

ABCA does not publish a consolidated cannabis-industry employment figure for the District, and the market's small, capped-license structure makes industry-wide workforce estimates difficult to verify. (Not Available.)

D.C.'s medical program does not currently operate a dedicated social equity licensing track comparable to neighboring Maryland's; with no new license application windows open, there is presently no active pathway for new equity-focused entrants into the regulated market. (Official.)

D.C.'s "gifting" shops — unlicensed operators that bundle cannabis with the purchase of another item under Initiative 71's gift allowance — represent a persistent, untaxed gray market operating alongside the regulated medical channel. The District does not publish an official size estimate for this gray market. (Official as to existence; Not Available as to market size.)

This report blends official ABCA program data with reputable policy-organization and media reporting on the Harris Rider and its market effects.

This report compiles data from the D.C. Alcoholic Beverage and Cannabis Administration, federal demographic sources, and reputable cannabis policy and industry media covering the Harris Rider and the District's medical program.